Wealth Management Partners’s Shockwave Medical SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-3,984
Closed -$1.3M – 121
2024
Q1
$1.3M Buy
3,984
+115
+3% +$28.2K 0.66% 34
2023
Q4
$737K Sell
3,869
-800
-17% -$151K 0.41% 50
2023
Q3
$930K Buy
4,669
+756
+19% +$179K 0.58% 37
2023
Q2
$1.12M Sell
3,913
-1,649
-30% -$458K 0.7% 29
2023
Q1
$1.21M Buy
5,562
+562
+11% +$110K 0.84% 25
2022
Q4
$925K Buy
5,000
+2,000
+67% +$506K 0.77% 31
2022
Q3
$739K Buy
3,000
+1,000
+50% +$254K 0.65% 39
2022
Q2
$385K Buy
+2,000
New +$353K 0.34% 61

Other funds holding SWAV

Wealth Management Partners's SWAV Position: Q2 2024 in Review

Wealth Management Partners sold out of Shockwave Medical (SWAV) in Q2 2024, closing a stake of 3,984 shares — an estimated $1.3M sold.

Wealth Management Partners first reported a position in SWAV in Q2 2022 and held it in 8 quarters. The position peaked at $1.3M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Wealth Management Partners reported no remaining Shockwave Medical position as of Q2 2024 after selling out during the quarter.
  • Wealth Management Partners sold 3,984 Shockwave Medical shares in Q2 2024, an estimated $1.3M.
  • Wealth Management Partners first reported a position in Shockwave Medical in Q2 2022 and held it in 8 quarters.
  • Wealth Management Partners's Shockwave Medical position peaked at $1.3M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical as of Q2 2024.

Based on Wealth Management Partners's 13F filing for Q2 2024, filed 12 Jul 2024.